BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 9565461)

  • 41. Successful treatment of refractory ascites in a child with transjugular intrahepatic portosystemic shunt.
    Lee WS; McKiernan PJ; de Ville de Goyet JV; Tanner MS; John PR
    Acta Paediatr; 2001 Nov; 90(11):1352-5. PubMed ID: 11808914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predictors of clinical response to transjugular intrahepatic portosystemic shunt (TIPS) in cirrhotic patients with refractory ascites.
    Deschênes M; Dufresne MP; Bui B; Fenyves D; Spahr L; Roy L; Lafortune M; Pomier-Layrargues G
    Am J Gastroenterol; 1999 May; 94(5):1361-5. PubMed ID: 10235219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management of ascites in children.
    Lane ER; Hsu EK; Murray KF
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1281-92. PubMed ID: 26325252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ascites and Chronic Liver Disease in Children.
    Bolia R; Srivastava A
    Indian J Pediatr; 2024 Mar; 91(3):270-279. PubMed ID: 37310583
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [New therapeutic paradigm and concepts for patients with cirrhotic refractory ascites].
    Wang SZ; Ding HG
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):249-253. PubMed ID: 28494541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of ascites: old and new remedies.
    Inturri P; Graziotto A; Rossaro L
    Dig Dis; 1996; 14(3):145-56. PubMed ID: 8861522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapy of the refractory ascites: Total paracentesis vs. TIPS.
    La Mura V; Salerno F
    Gastroenterol Hepatol; 2016; 39(7):477-80. PubMed ID: 26596208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.
    Ginés P; Arroyo V; Quintero E; Planas R; Bory F; Cabrera J; Rimola A; Viver J; Camps J; Jiménez W
    Gastroenterology; 1987 Aug; 93(2):234-41. PubMed ID: 3297907
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Intrahepatic percutaneous portosystemic shunt and refractory ascites].
    Fernández-Esparrach G; Arroyo V
    Gastroenterol Hepatol; 1997 Nov; 20(9):459-60. PubMed ID: 9445741
    [No Abstract]   [Full Text] [Related]  

  • 50. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transjugular intrahepatic portosystemic stent shunt for ascites.
    Fabrega AJ; Martin M
    N Engl J Med; 1995 Sep; 333(13):878-9. PubMed ID: 7651491
    [No Abstract]   [Full Text] [Related]  

  • 52. [Surgical treatment of intractable ascites in cirrhosis. In favor of a rationale for therapeutic indications].
    Franco D; Vons C; Smadja C
    Acta Gastroenterol Belg; 1986; 49(1):50-9. PubMed ID: 3766060
    [No Abstract]   [Full Text] [Related]  

  • 53. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
    N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transjugular intrahepatic portosystemic shunt (TIPS) for the treatment of refractory ascites.
    Williams DB; Waugh R; Selby W
    Aust N Z J Med; 1998 Oct; 28(5):620-6. PubMed ID: 9847951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
    Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
    Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The surgical treatment of diuretic-resistant ascites in liver cirrhosis].
    Khokhlov AV
    Vestn Khir Im I I Grek; 1996; 155(4):107-9. PubMed ID: 8992706
    [No Abstract]   [Full Text] [Related]  

  • 57. Liver Cirrhosis and Kidney.
    Gerbes AL
    Dig Dis; 2016; 34(4):387-90. PubMed ID: 27170393
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitigation of Sarcopenia after Peritoneovenous Shunt Placement in Patients with Refractory Ascites.
    Currie BM; Bakhtiar M; Nadolski GJ; Soulen MC
    J Vasc Interv Radiol; 2023 Apr; 34(4):633-638. PubMed ID: 36563934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution.
    Martinet JP; Fenyves D; Legault L; Roy L; Dufresne MP; Spahr L; Lafortune M; Pomier-Layrargues G
    Dig Dis Sci; 1997 Jan; 42(1):161-6. PubMed ID: 9009133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.